Clinical RoundupFree Partner Therapeutics begins phase III study of leukine + ipilumimab and nivolumab front-line melanoma September 18, 2020Vol.46 No.35
Clinical RoundupFree Despite progress, adolescents and young adults face substantial cancer disparities by race/ethnicity September 18, 2020Vol.46 No.35
Clinical RoundupFree Study: Rubbery properties help RNA nanoparticles target tumors efficiently and quickly leave body September 18, 2020Vol.46 No.35
Clinical Roundup JNCCN study sheds light on multi-organ adverse events from immunotherapy September 11, 2020Vol.46 No.34
Clinical Roundup City of Hope scientists combine oncolytic virus and CAR T in solid tumors September 11, 2020Vol.46 No.34
Clinical Roundup Phase II study of Tabrecta shows positive ORR for NSCLC September 11, 2020Vol.46 No.34
Clinical Roundup NCCS survivorship data demonstrates prevailing “doctor knows best” mindset September 04, 2020Vol.46 No.33
Clinical Roundup Phase III VIALE-A trial of venetoclax combination meets OS endpoint in AML September 04, 2020Vol.46 No.33
Clinical Roundup Opdivo + Yervoy demonstrate durable survival benefit vs. chemotherapy in mesothelioma September 04, 2020Vol.46 No.33
Clinical Roundup Opdivo meets OS, PFS endpoints in phase III CheckMate-649 trial September 04, 2020Vol.46 No.33
